News

electricity

Intelligent charging of electric vehicles

Tuesday 15/11/2022

VUB and Brussels startup Octave join hands in the CLEVER project to develop novel energy management systems for second-life battery energy storage system (BESS) in combination with intelligent charging of electric vehicles (EVs).

animab

Animab raises 10 mio euro

Monday 14/11/2022

VIB-VUB spin-off Animab, which is developing a new class of orally administered antibodies for animal health, announced the successful closing of its Series A round. The proceedings will be used to bring its lead product to market and to expand the pipeline of antibody products in animal health.

Jan Steyaert

Prestigious Gabbay Award for Jan Steyaert

Thursday 10/11/2022

Jan Steyaert, director of the VIB-VUB Center for Structural Biology and professor at Vrije Universiteit Brussel (VUB), is the first Belgian scientist to receive the prestigious Jacob and Louise Gabbay Award for outstanding science with a translational character.

Metaverse innovator and imec VUB spin-off Swave Photonics

New CEO for metaverse innovator Swave, a spin-off from imec and VUB

Thursday 03/11/2022

Swave Photonics has announced that semiconductor industry veteran Mike Noonen takes the helm as CEO to lead metaverse innovator’s next stage of growth. Noonen joins Swave to expand the investment and commercialisation of immersive 3D, gigapixel holographic projection chips for a wide range of emerging AR/VR and metaverse applications benefiting from truly realistic 3D experiences.

Bru-brain

Memory clinic Bru-BRAIN internationally recognised

Wednesday 12/10/2022

The Memory clinic Bru-BRAIN is included in the European Alzheimer's consortium, making it internationally recognised. Bru-BRAIN is led by Sebastiaan Engelborghs, head of Neurology of UZBrussel and NEUR-o-AIMS, an IoF-funded consortium. The memory clinic was founded at the beginning of 2021 with UZBrussels as a home base.

weave.ly

Weave.ly, a VUB spin-off, completes first capital round

Wednesday 28/09/2022

Weave.ly, a VUB spin-off, has completed a first capital round of € 300.000. The capital round was led by interuniversity seed and growth fund Qbic and completed by finance&invest.brussels. Weave.ly developed a pioneering no-code platform that allows for partial software development process automation.

MDD

INSTA-MD: Inflammation-based Stratification for immune-Targeted Augmentation in Major Depressive disorder

Tuesday 20/09/2022

Unfortunately, some applied research projects within the biomedical field do not reach the patient due to a lack of industrial interest.

congenital CMV

Prenatal valaciclovir-treatment for congenital CMV (Cytomegalovirus)

Wednesday 14/09/2022

Unfortunately, some applied research projects within the biomedical field do not reach the patient due to a lack of industrial interest.

Hugo Thienpont 2018

Hugo Thienpont remains vice-rector Innovation & Industry Relations of VUB

Thursday 08/09/2022

We are very pleased that our new rector Jan Danckaert has chosen to prolong the mandate of Hugo Thienpont as vice-rector Innovation and Industry Relations, so that he can continue to pursue his policy.

lower back pain

PIANISSIMO: Opioid detoxification for patients with Persistent Spinal Pain Syndrome Type II

Wednesday 07/09/2022

Unfortunately, some applied research projects within the biomedical field do not reach the patient due to a lack of industrial interest.

VUB spin-off eTheRNA lab

39M euro invested in VUB spin-off eTheRNA to boost mRNA therapeutics

Thursday 01/09/2022

mRNA leading expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers invest in EUR 39M Series B2 financing of mRNA technology platform company eTheRNA to expand its expertise and capabilities as a one-stop service to bring RNA-based research and products from the lab to the clinic. Read the full article on VUB Today Read the article in De Tijd

wandelende mensen

ACTIVE-AGE@home: a home-based functional exercise program for community-dwelling frail older adults

Tuesday 30/08/2022

Unfortunately, some applied research projects within the biomedical field do not reach the patient due to a lack of industrial interest.

First
Previous
…
10
11
12
13
14 (current)
15
16
17
18
…
Next
Last